Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies-Reference-Cited by-同舟云学术

Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies

Published:2019-08-22 Issue:16 Volume:4 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Arotcarena Marie-Laure^ORCID,Bourdenx Mathieu,Dutheil Nathalie,Thiolat Marie-Laure,Doudnikoff Evelyne,Dovero Sandra^ORCID,Ballabio Andrea,Fernagut Pierre-Olivier^ORCID,Meissner Wassilios G.^ORCID,Bezard Erwan^ORCID,Dehay Benjamin^ORCID

Funder

The LABEX Brain, the University of Bordeaux and the Centre National de la Recherche Scientifique

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/129719/files/pdf

Reference68 articles.

1. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

2. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB

3. Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death;Bourdenx;Front Neuroanat,2014

4. Pathogenic Lysosomal Depletion in Parkinson's Disease

5. Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The AAV-α-Synuclein Model of Parkinson’s Disease: An Update;Journal of Parkinson's Disease;2024-09-03

2. Mitochondria-lysosome-extracellular vesicles axis and nanotheranostics in neurodegenerative diseases;Experimental Neurology;2024-06

3. In vivo bioluminescence imaging of the intracerebral fibroin-controlled AAV-α-synuclein diffusion for monitoring the central nervous system and peripheral expression;Scientific Reports;2024-04-27

4. Altered TFEB subcellular localization in nigral neurons of subjects with incidental, sporadic and GBA-related Lewy body diseases;Acta Neuropathologica;2024-04-06

5. Recent Advances in Clinical Trials in Multiple System Atrophy;Current Neurology and Neuroscience Reports;2024-02-28